| NEW-CUSTOMERS |
NEW-CUSTOMERS |
92%
|
Private-label contract manufacturing sales increased 14% primarily due to increased orders from one of our largest customers and several of our other existing customers and shipments to new customers… |
| ONE-OF-OUR-LARGEST-CUSTOMERS |
ONE-OF-OUR-LARGEST-CUSTOMERS |
92%
|
Private-label contract manufacturing sales increased 14% primarily due to increased orders from one of our largest customers and several of our other existing customers and shipments to new customers… |
| OTHER-EXISTING-CUSTOMERS |
OTHER-EXISTING-CUSTOMERS |
92%
|
Private-label contract manufacturing sales increased 14% primarily due to increased orders from one of our largest customers and several of our other existing customers and shipments to new customers… |
| OUR-LARGEST-PRIVATE-LABEL-CONTRACT-MANUFACTURING |
OUR-LARGEST-PRIVATE-LABEL-CONTRACT-MANUFACTURING |
92%
|
Revenue concentration for our largest private-label contract manufacturing customer as a percentage of total net sales for the nine months ended March 31, 2026 was 27%, and revenue concentration for … |
| SEVERAL-OF-OUR-OTHER-EXISTING-CUSTOMERS |
SEVERAL-OF-OUR-OTHER-EXISTING-CUSTOMERS |
92%
|
Private-label contract manufacturing sales increased 14% primarily due to increased orders from one of our largest customers and several of our other existing customers and shipments to new customers… |
| LARGEST-PRIVATE-LABEL-CONTRACT-MANUFACTURING-CUS |
LARGEST-PRIVATE-LABEL-CONTRACT-MANUFACTURING-CUS |
90%
|
Revenue concentration from our largest private-label contract manufacturing customer as a percentage of our total net sales was 42% in fiscal 2024 |
| THREE-LARGEST-CUSTOMERS |
THREE-LARGEST-CUSTOMERS |
90%
|
During the fiscal year ended June 30, 2024, sales to our three largest customers were approximately 68% of our consolidated net sales |
| LICENSEES |
LICENSEES |
85%
|
commercializing our patent estate through sales of beta-alanine under our CarnoSyn®, SR CarnoSyn® and TriBsyn® trademarks, royalties from license agreements, and potentially additional contract manuf… |
| CARNOSYN-BRANDS-PRODUCT-OFFERINGS |
CARNOSYN-BRANDS-PRODUCT-OFFERINGS |
80%
|
We continue to invest in research and development for the expansion of our CarnoSyn® Brands product offerings. |
| LARGEST-CUSTOMER |
LARGEST-CUSTOMER |
80%
|
We have in the past and expect to continue to derive a significant portion of our revenues from a relatively limited number of customers |
| SHIMIZU-CHEMICAL-CORPORATION |
SHIMIZU-CHEMICAL-CORPORATION |
62%
|
, NAIE obtained FSSC 22000 certification in May 2024 following a successful food safety audit of its operations. We believe these licenses, certifications and NAIE’s manufacturing capabilities help s… |